AEVA Biotech Srl

AEVA develops diagnostic tools for the analysis of the extracellular vesicles - that is to say nanoparticles released by cells into biological fluids - with the aim of detecting biomarkers in liquid biopsies of cancer patients and monitoring how the tumor evolves and responds to therapies.